Login

News

Food for thought: when excess safety precautions clash with reality on the ground (Ebola outbreak, see News tab)

05 September 2018

The Challenges of Poliovirus Eradication, by J.Yelle

12 January 2017

Following the successful efforts to wipe out the virus of Smallpox (Variola virus) that started in the 1950s and officially realized their goal in 19803, the World Health Organization (WHO) made a commitment in 1988 to eradicate Poliovirus and poliomyelitis and achieve a Polio-free world by 2000. This ambitious project proved to be much more challenging than initially anticipated.

See complete publication in "NEWS" section (Tab)

The Urgent Need for Broad-Spectrum Antiviral Drugs, by J. Yelle

18 March 2015

Conferences

The Mission

Welcome to Antiviral InteliStrat!

Viral diseases represent a real challenge for modern medicine with the recent emergence of new viral threats worldwide such as Ebola, Avian Influenza, MERS, HIV/AIDS and SARS. Reliable information on products and strategies proposed to face this last frontier of infectious diseases remains crucial to support the effective development of new preventive and therapeutic treatments.

Antiviral InteliStrat Inc. intends to become the main leading source of information on antiviral drugs and vaccines research and development, and provide its vast knowledge of the virology domain to individuals involved in science, marketing and decision making in the biotech and pharmaceutical industry, as well as the academic community.

To achieve this goal, the company has created and is now offering the following products to its customers:

The Products

1. Database: VIROPENDIUM

2. Documents

3. Other Expertise, Know-how and Support

1. Database

Antiviral InteliStrat has created the most complete, up-to-date Database currently available on antiviral drugs and vaccines. Focused exclusively on viruses, this Database called VIROPENDIUM regroups over 3700 Product files containing detailed information on compounds and vaccines related to prevention or treatment of viral diseases worldwide. VIROPENDIUM is being constantly updated to reflect new developments in the antiviral arena.

The company is offering this unique source of information on a subscription basis to the biotech and pharmaceutical industry, along with the academia. Customers can access the Database through flexible subscription options designed to fit their specific needs.

Antiviral Database VIROPENDIUM

Dedicated only to antiviral drugs and vaccines, with the most complete set of information currently available to scientists, analysts, and drug development / health specialists;

Based on information collected in its database, Antiviral InteliStrat prepares analyses, reviews and digests covering various aspects of the rapidly evolving antiviral research and development world.

These documents are prepared on a regular basis and made available to help scientists and decision-makers active at different levels in virology, who have time-constraints and need easy-to-read overviews of the antiviral treatment and prevention R&D and market for different types of viruses. The documents aim to cover the following areas:

• Competitive intelligence
• Pharma’s current pipeline
• Specific products and mechanisms of action
• Research directions and trends
• Potential collaborations and partnerships (a list of about 350 companies active in antivirals is available)
• Creative thinking, new ideas and strategies in the lab and at the management level (including a new list of over 330 lead compounds showing positive antiviral activity in lab tests, with chemical structures, activity data and more, classified according to virus types and families)

The documents are listed on the "Documents" page of this website and can be easily dowloaded upon payment through a user-friendly PayPal® online system.